Doctors welcome hepatitis C drug rivals, Gilead still leads
April 11, 2014 at 01:00 AM EDT
LOS ANGELES/LONDON April 11 (Reuters) - Doctors at a key medical conference welcomed the prospect of more new drugs to treat the liver-destroying hepatitis C virus, while agreeing that Gilead Sciences Inc continues to lead the effort.
